Home
Storia in 1 fonti
BLOG: Epithelium-on cross-linking allows for interventional keratoconus approach
Epioxa obtained FDA approval in October 2025, which makes it the first and only FDA-approved epithelium-on, oxygen-enriched corneal cross-linking treatment for patients with keratoconus. Epioxa (Glaukos) is bioactivated by UV light and designed to improve corneal penetration through an intact epithelium. It is intended to be used with the company’s O2n system, which delivers pulsed
Raccontata da
healio.com
Timeline cronologica
- ·
Epioxa for keratoconus provides patient comfort, quicker recovery time
KIAWAH ISLAND, S.C. — In this video from Kiawah Eye & Retina, Beeran B. Meghpara, MD, highlights the benefits of Epioxa from Glaukos in the treatment of keratoconus.
- ·
BLOG: Epithelium-on cross-linking allows for interventional keratoconus approach
Epioxa obtained FDA approval in October 2025, which makes it the first and only FDA-approved epithelium-on, oxygen-enriched corneal cross-linking treatment for patients with…